Indoco Remedies share news, announcements and annual reports
NSE: INDOCOBSE: 532612Pharmaceuticals & BiotechnologySmall Cap
Indoco Remedies Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2005
Last close ₹208.30down ₹1.20 (0.57%)BSE ₹208.35
Share price at the NSE close on 30 Oct 2026. Previous close ₹209.50.
30 Oct: open ₹208.65, high ₹210.00, low ₹205.10
52-week range of traded prices to 30 Oct 2026
₹162.19Low, 30 Mar 2026₹288.00High, 6 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,923 Cr1,173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 60.20
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹132 crore of one-off items, the largest of them in the quarter to Jun 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.10%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹132 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −10.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.96
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 64,72755.0% delivered
Indoco Remedies board meetings
103 filed, newest first. Page 2 of 3.
Mar 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Mar 2015
Jan 2015
16 Jan · Board meeting
Inter-alia, for taking on record the un-audited financial results for the quarter ended December 31, 2014.
Oct 2014
9 Oct · Board meeting
Inter-alia, for taking on record the unaudited financial results for the second quarter ended September 30, 2014.Trading window of the Company shall remain closed w.e.f October 10, 2014 and shall end after 24 hours from the conclusion of the aforesaid Board Meeting.
Jul 2014
16 Jul · Board meeting
Inter-alia, for taking on record the unaudited financial results for the first quarter ended June 30, 2014
May 2014
28 May · Board meeting
Board of Directors in its meeting held on May 28, 2014 has approved appointment of Dr. Anand Nadkarni (DIN 06881461) as Additional Non Executive Director of the Company liable to retire by rotation w.e.f. May 28, 2014.
Jan 2014
13 Jan · Board meeting
Inter-alia, for taking on record the un-audited financial results for the third quarter ended December 31, 2013.
Oct 2013
14 Oct · Board meeting
For approval of the unaudited accounts for the Quarter ended 30th September 2013.
Jul 2013
10 Jul · Board meeting
To approve the Unaudited Results for the Quarter ended 30th June 2013.
May 2013
Jan 2013
29 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 29, 2013, has considered the letter of resignation received from Mr. D. M. Sukthankar as Director of the Company and after due deliberations it was decided to accept his resignation.16 Jan · Board meeting
Inter-alia, for taking on record the un-audited financial results for the third quarter ended December 31, 2012.
Oct 2012
17 Oct · Board meeting
Inter-alia, for taking on record the un-audited financial results for the second quarter ended September 30, 2012.
Jul 2012
16 Jul · Board meeting
Inter-alia, for taking on record the un-audited financial results for the first quarter ended June 30, 2012.
May 2012
16 May · Board meeting
Inter alia, to consider the following : 1) Audited Financial Results for the quarter/year ended on March 31,2012. 2)Recommendation of dividend for the financial year 2011-12,if any ,subject to approval of shareholders in the ensuing Annual General Meeting.9 May · Board meeting
To allot the Bonus Shares.2 May · Board meeting
To approve the following: (1) To fix record date for Sub-division of shares Rs.10/- each to Rs. 2/- each. (2) To fix record date for issue of bonus shares.
Mar 2012
22 Mar · Board meeting
To consider, inter alia, the following business: (a) To consider a prosposal for sub division of shares of Rs.10/- each. (b) To consider a proposal for increasing the Authorized Share Capital and Consequent amendments to Memorandum of Association of the Company. (c) To consider a proposal for issue of Bonus Shares.
Feb 2012
Jan 2012
31 Jan · Board meeting
Inter-alia, for taking on record the un-audited financial results for the third quarter ended December 31, 2011.
Oct 2011
22 Oct · Board meeting
At the meeting of the Board of Directors held on October 20, 2011, the letter dated September 08, 2011 received from Dr. M. R. Narvekar tendering his resignation as the Director of the Company was considered and after due consideration it was decided to accept his resignation with effect from October 20, 2011.
Sep 2011
29 Sep · Board meeting
Inter-alia, for taking on record the un-audited financial results for the second quarter ended September 30, 2011.
Jul 2011
5 Jul · Board meeting
Inter alia, for taking on record the un-audited financial results for the first quarter ended June 30, 2011.
May 2011
11 May · Board meeting
To consider, inter-alia, the following businesses: (1) The audited financial results for the year ended March 31, 2011, and; (2) recommendation of final dividend, if any, for the financial year 2010-2011.
Apr 2011
5 Apr · Board meeting
Inter-alia, to consider the Un-audited Financial Results for the last quarter ended March 31, 2011.
Jan 2011
4 Jan · Board meeting
Inter-alia, to consider the un-audited financial results for the third quarter ended December 31, 2010.
Oct 2010
6 Oct · Board meeting
Inter-alia, to consider the un-audited financial results for the second quarter ended September 30, 2010.
Jul 2010
14 Jul · Board meeting
Inter-alia, for taking on record the un-audited financial results for the first quarter ended June 30, 2010.
May 2010
21 May · Board meeting
To consider, inter-alia, the following businesses: (1) To consider the audited financial results for the year ended March 31, 2010, and; (2) To consider recommendation of final dividend, if any, for the financial year 2009-2010.
Apr 2010
16 Apr · Board meeting
For considering, inter-alia, the unaudited financial results of the Company for the fourth quarter ended March 31, 2010.
Jan 2010
13 Jan · Board meeting
Meeting on 27 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
15 Oct · Board meeting
Meeting on 30 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
16 Jul · Board meeting
To consider, inter-alia, the following businesses: (a) To consider and take on record the unaudited financial results of the company for the quarter ended June 30, 2009, (b) To consider the audited financial results for the year ended March 31, 2009 and (c) To consider recommendation of final dividend, if any, for the financial year 2008-2009.
Apr 2009
13 Apr · Board meeting
To consider inter-alia, the unaudited financial results of the Company for the fourth quarter ended March 31, 2009.
Jan 2009
13 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
18 Nov · Board meeting
For the purpose of considering a proposal for declaration of an interim dividend for the financial year 2008-2009.
Oct 2008
21 Oct · Board meeting
Meeting of the Board of Directors scheduled for October 23, 2008 for considering inter-alia, the unaudited financial results for the second quarter ended September 30, 2008 has been rescheduled and will be held on October 31, 2008.14 Oct · Board meeting
Inter-alia, for considering the unaudited financial results for the second quarter period from July 01, 2008 to September 30, 2008.
Sep 2008
4 Sep · Board meeting
Board Meeting of the Company convened today i.e. September 02, 2008 for consideration of audited financial results and declaration of dividend, if any, has been adjourned, and adjourned meeting will be held on September 05, 2008, for consideration of the audited financial results and declaration of dividend, if any, will be considered for the financial year ended March 31, 2008.
Aug 2008
20 Aug · Board meeting
Inter-alia, for considering the audited financial results for the financial year ended on March 31, 2008 and recommendation of dividend for the financial year 2007-2008.
Jul 2008
21 Jul · Board meeting
Inter alia, for taking on record the un-audited financial results for the first quarter ended June 30, 2008.
Apr 2008
21 Apr · Board meeting
Inter alia, to consider and take on record the unaudited financial results for third and the last quarter ended March 31, 2008.
Jan 2008
29 Jan · Board meeting
Vide its letter dated January 29, 2008, that: "At the meeting of the Board of Directors of Indoco Remedies Limited (IRL) held today, it has been decided to take up 100% equity stake in Shree Herbal Technologies Ltd (SHTL) for a consideration of Rs. 251.00 lacs. The investment will make SHTL a wholly owned subsidiary of Indoco. SHTL is an unlisted Company with registered office at Delhi. It was incorporated in 2005 and is yet to commence manufacturing operations. Indoco will leverage its manufacturing capacity from the investment".21 Jan · Board meeting
Inter-alia, for considering the unaudited financial results for the second quarter from October 01, 2007 to December 31, 2007.
Oct 2007
23 Oct · Board meeting
Inter-alia, for considering the unaudited financial results for the first quarter period from July 01, 2007 to September 30, 2007.